Portfoliotracker

Eurofins-Cerep SA

ALECR.PA · PARIS · Healthcare Diagnostics & Research 78/100 B

15 000,00 €
▼ −3 400,00 (−18,48 %)
Closed delayed by 15 min
Price as of 17. 11. 11:30, fetched 17. 11. 17:36
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score78 / 100 Market cap75,7 mil. € P/E15,8 Forward P/E– P/S1,8 P/B1,0 EV/EBITDA8,4 Dividend yield– FCF yield– EPS1 540,14 € Net margin11,6 % Return on equity6,5 % Beta0,11 Debt / equity0,00
52-week range 15 000,00 to 18 600,00
3-month average volume0,0 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company also provides research services, including compound management, and high-throughout screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and is based in Celle-Lévescault, France. Eurofins-Cerep SA is a subsidiary of Eurofins Discovery Services LUX Holding SARL.

Country
France
Data since
12. 4. 2000

Explore further

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account